Research Analysts Offer Predictions for Stericycle, Inc.’s Q3 2017 Earnings (SRCL)
Stericycle, Inc. (NASDAQ:SRCL) – Jefferies Group cut their Q3 2017 EPS estimates for Stericycle in a research note issued to investors on Tuesday. Jefferies Group analyst S. Dodge now forecasts that the business services provider will post earnings per share of $1.13 for the quarter, down from their prior forecast of $1.15. Jefferies Group currently has a “Buy” rating and a $108.00 price objective on the stock. Jefferies Group also issued estimates for Stericycle’s Q4 2017 earnings at $1.22 EPS, FY2017 earnings at $4.59 EPS and FY2018 earnings at $4.80 EPS.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The business had revenue of $917.70 million for the quarter, compared to the consensus estimate of $902.81 million. During the same quarter in the prior year, the business earned $1.18 earnings per share. Stericycle’s revenue for the quarter was up 2.9% on a year-over-year basis.
WARNING: This story was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/10/18/research-analysts-offer-predictions-for-stericycle-inc-s-q3-2017-earnings-srcl.html.
A number of other equities research analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. William Blair reaffirmed an “ourperform” rating on shares of Stericycle in a research report on Thursday, September 14th. Barclays PLC reaffirmed an “overweight” rating and issued a $100.00 target price on shares of Stericycle in a research report on Wednesday, August 9th. BidaskClub downgraded shares of Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Finally, BMO Capital Markets began coverage on shares of Stericycle in a research report on Thursday, June 29th. They issued a “market perform” rating and a $81.00 target price for the company. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. Stericycle presently has a consensus rating of “Hold” and a consensus price target of $81.25.
Stericycle (NASDAQ:SRCL) opened at 71.27 on Wednesday. Stericycle has a 1-year low of $68.62 and a 1-year high of $88.00. The stock’s market cap is $6.08 billion. The company has a 50-day moving average price of $71.20 and a 200 day moving average price of $77.45.
Institutional investors have recently modified their holdings of the company. Kernodle & Katon Asset Management Group LLC purchased a new position in shares of Stericycle during the 1st quarter worth $100,000. Pacer Advisors Inc. boosted its stake in shares of Stericycle by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock worth $143,000 after acquiring an additional 145 shares during the last quarter. Invictus RG purchased a new position in shares of Stericycle during the 1st quarter worth $145,000. Ameritas Investment Partners Inc. purchased a new position in shares of Stericycle during the 1st quarter worth $169,000. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of Stericycle by 8.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock worth $194,000 after acquiring an additional 200 shares during the last quarter. Institutional investors and hedge funds own 93.54% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.